title: ["Why is it always the heart which suffers from myocardial infarction?" The "Marburg hypothesis" of the pathogenesis of atherosclerosis].
abstract: There is no question that cholesterol, especially low-density lipoprotein (LDL) cholesterol, represent a major cardiovascular risk factor. The so-called lipid hypothesis has been proven by almost all epidemiologic studies, animal studies and, most importantly, by interventional studies with lipid-lowering drugs, especially statins. However, despite our better understanding of atherogenesis we cannot explain why atherosclerosis occurs most frequently and severely on coronary arteries rather than on other arteries such as those of the hands or feet. In addition, the "lipid hypothesis" is unable to explain the dramatic change in severity of a far more generalized atherosclerosis in patients suffering from diabetes mellitus.Recently, we studied the effects of fatty acids on endothelial integrity and found a dramatic increase in apoptosis under fatty acid exposition. Since it is well known that the heart depends highly on fatty acid delivery to cover its energy demand, we hypothesize that the heart becomes the victim of its energy demand. With the so-called Marburg hypothesis of atherogenesis we can explain the fact why especially the arteries of the heart show early atherosclerotic lesions, but also the fact why patients with diabetes develop more generalized atherosclerosis. Finding mechanisms to reduce the presence of fatty acids within the arterial wall might prevent plaque destabilization and could be a potential target in our fight against atherosclerosis.
authors.affiliation: Zentrum Innere Medizin-Kardiologie, Universitätsklinikum Giessen-Marburg, Philipps-Universität Marburg, Marburg, Germany. Juergen.schaefer@staff.uni-marburg.de
authors.forename: In Frau Susanne
authors.initials: IF
authors.lastname: Memoriam Klumpp
authors.forename: Jürgen R
authors.initials: JR
authors.lastname: Schaefer
authors.forename: Birgit
authors.initials: B
authors.lastname: Hufnagel
authors.forename: Bernhard
authors.initials: B
authors.lastname: Maisch
authors.forename: Josef
authors.initials: J
authors.lastname: Krieglstein
mesh_terms: D050197:Atherosclerosis / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D008955:Models, Cardiovascular; D009203:Myocardial Infarction / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*
chemical_list: D005227:Fatty Acids
references.citation: J Intern Med. 2009 Jun;265(6):689-97
references.pmid: 19226374
references.citation: Lancet. 2005 Nov 26;366(9500):1849-61
references.pmid: 16310551
references.citation: Eur Heart J. 2010 Jan;31(1):92-9
references.pmid: 19797259
references.citation: Fundam Clin Pharmacol. 2010 Aug;24(4):469-76
references.pmid: 20030737
references.citation: Atherosclerosis. 2005 Jun;180(2):245-54
references.pmid: 15910849
references.citation: Nature. 2000 Sep 14;407(6801):233-41
references.pmid: 11001066
references.citation: Nature. 2002 Dec 19-26;420(6917):868-74
references.pmid: 12490960
references.citation: J Clin Endocrinol Metab. 2006 Jul;91(7):2542-7
references.pmid: 16595593
references.citation: Eur J Clin Invest. 2007 Oct;37(10):774-82
references.pmid: 17888088
references.citation: Nat Rev Drug Discov. 2002 Feb;1(2):122-30
references.pmid: 12120093
references.citation: Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1904-9
references.pmid: 15319266
references.citation: Atherosclerosis. 2005 Jun;180(2):417-8
references.pmid: 15910870
references.citation: J Lipid Res. 1994 Jul;35(7):1152-60
references.pmid: 7525821
references.citation: Neurochem Int. 2003 Jun;42(7):555-60
references.pmid: 12590938
references.citation: FEBS Lett. 1998 Oct 23;437(3):229-32
references.pmid: 9824296
references.citation: J Clin Invest. 1992 Feb;89(2):373-80
references.pmid: 1737833
references.citation: Nat Med. 2002 Nov;8(11):1249-56
references.pmid: 12411952